相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: Data from a multicentre prospective registry
Jose V. Monmeneu Menadas et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2022)
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
Emmanuel Sorbets et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Safety of regadenoson for vasodilation in cardiac MRI stress tests
G. Bastarrika et al.
RADIOLOGIA (2020)
Prognostic role of stress cardiac magnetic resonance in the elderly
Alberto Esteban-Fernandez et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2020)
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
Emmanuel Sorbets et al.
EUROPEAN HEART JOURNAL (2020)
Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging
Alejandra Garcia-Baizan et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2019)
Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis
Ibrahim Danad et al.
EUROPEAN HEART JOURNAL (2017)
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
R. van Dijk et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2017)
Stress Perfusion CMR in Patients With Known and Suspected CAD
Gabriella Vincenti et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry
Jose V. Monmeneu Menadas et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: A quantitative analysis from the ADVANCE MPI trials
John J. Mahmarian et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2015)
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
Furqan H. Tejani et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2014)
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge
Yasmeen Golzar et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial
Juerg Schwitter et al.
EUROPEAN HEART JOURNAL (2013)
Prognostic Value of Stress Cardiac Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease A Systematic Review and Meta-Analysis
Michael J. Lipinski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
Sujethra Vasu et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2013)
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings
J. P. Khoo et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
Edward V. R. DiBella et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2012)
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
Bruce M. Prenner et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2012)
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
Nicole M. Bhave et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2012)
Effect of body mass index on the efficacy, side effect profile, and plasma concentration of fixed-dose regadenoson for myocardial perfusion imaging
Eliana Reyes et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2011)
A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging
Fadi G. Hage et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2011)
Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome
Fadi G. Hage et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance
Theodoros D. Karamitsos et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2010)
Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus
Fadi G. Hage et al.
AMERICAN HEART JOURNAL (2009)
Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease
Theodoros D. Karamitsos et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2009)
Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine A Quantitative Analysis From the ADVANCE MPI 2 Trial
John J. Mahmarian et al.
JACC-CARDIOVASCULAR IMAGING (2009)
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations
W. Gregory Hundley et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2009)
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease:: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)
Gregory S. Thomas et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2008)
Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results
Manuel D. Cerqueira et al.
JACC-CARDIOVASCULAR IMAGING (2008)
Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease - A meta-analysis
Kiran R. Nandalur et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial
Ami E. Iskandrian et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2007)
Contrast-enhanced adenosine-stress magnetic resonance imaging - Feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting
P. Bernhardt et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
分享论文
